{"id":937604,"date":"2026-10-23T02:34:20","date_gmt":"2026-10-23T02:34:20","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/937604\/"},"modified":"2026-10-23T02:34:20","modified_gmt":"2026-10-23T02:34:20","slug":"cancer-vaccine-breakthrough-melanoma-mrna-treatment-set-to-cut-recurrence-by-42-per-cent-in-world-first","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/937604\/","title":{"rendered":"Cancer vaccine breakthrough: Melanoma mRNA treatment set to cut recurrence by 42 per cent in world-first"},"content":{"rendered":"<p data-testid=\"article-datetime\" class=\"sc-5cbbddda-5 hxoHkT\">October 23, 2026 \u2014 9:59am<\/p>\n<p>Save<\/p>\n<p class=\"sc-d1b14060-4 JmUoF\">You have reached your maximum number of saved items.<\/p>\n<p>Remove items from your <a href=\"https:\/\/www.smh.com.au\/goodfood\/saved\" class=\"sc-3f16ee48-12 sc-d1b14060-2 jyLmZI iQLtAb\" rel=\"nofollow noopener\" target=\"_blank\">saved list<\/a> to add more.<\/p>\n<p id=\"gift-modal-heading\" class=\"sc-cc1ff359-7 cTuVzZ\">No gift articles left<\/p>\n<p class=\"sc-cc1ff359-8 ctIrFC\">You&#8217;ve used all of your gift articles. 3 more will become available on the 1st of every month.<\/p>\n<p>Close<\/p>\n<p>AAA<\/p>\n<p>A world-first mRNA cancer vaccine has dramatically cut the risk of melanoma recurrence and death in a landmark large-scale trial that signals a new era in personalised cancer medicine.<\/p>\n<p>The Australian-led Phase 3 trial found that adding a tailor-made cancer vaccine reduced the risk of the recurrence of melanoma or death by 42 per cent, compared with patients who were only given the immunotherapy drug, pembrolizumab (sold as Keytruda).<\/p>\n<p><img decoding=\"async\" alt=\"Professor Georgina Long\u2019s trial results have attracted widespread international attention.\" loading=\"lazy\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/06b1a7a0e077a0bddf29844d8493c895108822d2.jpeg\"  class=\"sc-d34e428-1 ldCIuB\"\/>Professor Georgina Long\u2019s trial results have attracted widespread international attention.Tim Bauer<\/p>\n<p>Principal investigator, Professor Georgina Long, said she almost fell off her chair when she got the phone call relaying the trial results.<\/p>\n<p>\u201cI\u2019m not one prone to exaggeration, but this really is a very, very big leap forward in cancer,\u201d said Long, who pioneered immunotherapy treatments that transformed melanoma from a death sentence to a treatable disease.<\/p>\n<p>\u201cIt\u2019s all the clich\u00e9s: landmark moment, moon landing, first flight \u2013 it really is a foundational shift,\u201d she said from her apartment in Lisbon, Portugal, on sabbatical from her medical director role at the Melanoma Institute Australia, affiliated with the University of Sydney.<\/p>\n<p>Related Article<a href=\"https:\/\/www.smh.com.au\/national\/why-is-cancer-so-hard-to-cure-20230626-p5djiw.html\" tabindex=\"-1\" class=\"sc-cba76dee-0 hdiTqm\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" alt=\" \" loading=\"lazy\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/abd7734a6c3c3e68eca30c4eddada4bc54030ea7.jpeg\"  class=\"sc-d34e428-1 ioInpc\"\/><\/a><\/p>\n<p>Trial participants had all previously undergone surgery to remove their melanoma tumours. All 1137 were given pembrolizumab. Two-thirds were also given the <a class=\"inline-link\" href=\"https:\/\/www.smh.com.au\/national\/how-do-you-make-an-mrna-vaccine-and-how-do-they-work-20210421-p57l8o.html\" rel=\"nofollow noopener\" target=\"_blank\">personalised mRNA<\/a> therapeutic vaccine designed to enable their immune system to recognise and destroy their distinct cancer cells, while the remaining patients were given a placebo injection. <\/p>\n<p>The trial, funded by Merck and Moderna, found that, at two years, 82 per cent of trial patients who received both treatments were alive and melanoma-free, compared with 70 per cent of those who received pembrolizumab alone. <\/p>\n<p>Australian mRNA Cancer Vaccine Hub director Associate Professor Seth Cheetham said the combination of immunotherapy and the personalised cancer vaccine was an \u201cincredible breakthrough\u201d that would help usher in a new era in cancer research and treatment. <\/p>\n<p>\u201cThis is the first really large trial that\u2019s shown definitively that this technology works. It reduces the risk of recurrence or spread and results in better outcomes compared to standard of care,\u201d Cheetham said. <\/p>\n<p>\u201cThis is really the gold standard, and it\u2019s what the entire field\u2019s been waiting on,\u201d he said.<\/p>\n<p><img decoding=\"async\" alt=\"Professor Georgina Long and Professor Richard Scolyer were named joint Australians of the Year in 2024.\" loading=\"lazy\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/02452d0a68410869a0c37d7d67146d58cf802076.jpeg\"  class=\"sc-d34e428-1 ldCIuB\"\/>Professor Georgina Long and Professor Richard Scolyer were named joint Australians of the Year in 2024.Alex Ellinghausen<\/p>\n<p>Before checkpoint immunotherapies such as pembrolizumab, advanced melanoma was largely a death sentence, with most patients surviving for less than a year. Today, about half of patients with advanced melanoma are alive and effectively cured, but about half still die from the disease.<\/p>\n<p>Long has dedicated her career to the mission of zero deaths from melanoma, and to finding a cure for these treatment-resistant patients. She was named Australian of the Year in 2024 with her colleague and friend, the <a class=\"inline-link\" href=\"https:\/\/www.smh.com.au\/national\/i-d-be-delighted-to-be-remembered-as-a-proud-everyday-aussie-who-gave-it-a-crack-20260607-p604n5.html\" rel=\"nofollow noopener\" target=\"_blank\">late Professor Richard Scolyer.<\/a><\/p>\n<p>The new therapeutic vaccine is not for people who have never had cancer \u2013 it\u2019s designed to help protect patients against their melanoma recurring once their tumour has been removed.<\/p>\n<p>Pembrolizumab helps the body hunt down cancerous cells, which can evade the immune system by mimicking healthy cells. The vaccine goes a step further, by telling immune cells exactly what the cancer cells look like.<\/p>\n<p>The personalisation of the vaccine is critical, Long said.<\/p>\n<p>Trial researchers sequenced the genome of each person\u2019s tumour and compared it with their healthy cells to pinpoint the unique combination of mutations on the surface of their cancer cells, called neoantigens.<\/p>\n<p>They used this information to create tailor-made vaccines that could teach the immune system to recognise those neoantigens &#8211; up to 34 gene mutations unique to each patient &#8211; as a threat to be destroyed.<\/p>\n<p>Related Article<a href=\"https:\/\/www.smh.com.au\/national\/sydney-scientist-behind-moon-landing-cancer-vaccine-wins-top-science-prize-20260902-p60tqt.html\" tabindex=\"-1\" class=\"sc-cba76dee-0 hdiTqm\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" alt=\"Professor Georgina Long has won the Eureka Prize for Scientific Research.\" loading=\"lazy\" src=\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/10\/359272b83ef3c34e67f27695a2a131f3641bcfa1.jpeg\"  class=\"sc-d34e428-1 ioInpc\"\/><\/a><\/p>\n<p>Cheetham said: \u201cIt really is the antithesis of a one-size-fits-all approach, which has dominated cancer care for a long time.<\/p>\n<p>\u201cIt\u2019s pioneering a new kind of medicine, in which we are looking at each tumour individually and crafting a unique treatment for it,\u201d he said.<\/p>\n<p>Manufacturing such a personalised drug will be a logistical challenge, Cheetham said, especially for sick patients who will need timely access.<\/p>\n<p>In August, <a class=\"inline-link\" href=\"https:\/\/www.smh.com.au\/world\/north-america\/landmark-new-mrna-vaccine-could-prevent-skin-cancer-from-returning-companies-say-20260820-p60pwq.html\" rel=\"nofollow noopener\" target=\"_blank\">early hints at the trial\u2019s success<\/a> saw Moderna\u2019s shares surge more than 170 per cent in a single trading day. But on Friday, after the trial\u2019s results were leaked by an oncology website ahead of embargo, the company\u2019s shares plunged by over 25 per cent, in a trend stockbrokers call <a class=\"inline-link\" href=\"https:\/\/www.smh.com.au\/business\/markets\/buy-the-rumour-sell-the-fact-20100223-ovv5.html\" rel=\"nofollow noopener\" target=\"_blank\">\u201cbuy the rumour, sell the fact\u201d<\/a>.<\/p>\n<p>This phenomenon describes the propensity for investors to buy in ahead of an anticipated positive event, such as favourable trial results, pushing up the share price. Once the official news is revealed in further detail, those early traders cash out, to lock in their profits.<\/p>\n<p>The trial\u2019s interim analysis was initially due to be presented at the European Society for Medical Oncology on Sunday, ahead of publication in The New England Journal of Medicine.<\/p>\n<p>The vaccine was generally well-tolerated in patients. Long said she hoped the findings could also help patients with active advanced melanoma or other cancers, but research is ongoing.<\/p>\n<p>Dr Jessamy Tiffen, Acting Deputy Director and Head of the Centre for Cancer Innovations at the Centenary Institute, said don\u2019t throw away the sunblock.<\/p>\n<p>\u201cThis vaccine is in no way preventative &#8230; The best way to prevent melanoma is still to protect yourself from the sun,\u201d she said. <\/p>\n<p>Cheetham said melanoma cells were among the most promising targets for the vaccine, due to their abundance of mutations that make them appear quite distinct from healthy cells, whereas other cancers may not be as susceptible.<\/p>\n<p>But early trials of mRNA vaccines to treat lung and pancreatic cancers have some researchers optimistic, Cheetham said.<\/p>\n<p>Start the day with a summary of the day\u2019s most important and interesting stories, analysis and insights. <a class=\"inline-link\" href=\"https:\/\/www.smh.com.au\/newsletter-signup?newsletter=am&amp;utm_source=EditorialArticle&amp;utm_medium=ArticleText&amp;utm_campaign=Newsletters\" rel=\"nofollow noopener\" target=\"_blank\">Sign up for our Morning Edition newsletter<\/a>.<\/p>\n<p>Save<\/p>\n<p class=\"sc-d1b14060-4 JmUoF\">You have reached your maximum number of saved items.<\/p>\n<p>Remove items from your <a href=\"https:\/\/www.smh.com.au\/goodfood\/saved\" class=\"sc-3f16ee48-12 sc-d1b14060-2 jyLmZI iQLtAb\" rel=\"nofollow noopener\" target=\"_blank\">saved list<\/a> to add more.<\/p>\n<p id=\"gift-modal-heading\" class=\"sc-cc1ff359-7 cTuVzZ\">No gift articles left<\/p>\n<p class=\"sc-cc1ff359-8 ctIrFC\">You&#8217;ve used all of your gift articles. 3 more will become available on the 1st of every month.<\/p>\n<p>CloseFrom our partners<\/p>\n","protected":false},"excerpt":{"rendered":"October 23, 2026 \u2014 9:59am Save You have reached your maximum number of saved items. Remove items from&hellip;\n","protected":false},"author":2,"featured_media":937605,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[64,63,99],"class_list":["post-937604","post","type-post","status-publish","format-standard","has-post-thumbnail","category-business","tag-au","tag-australia","tag-business"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/937604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=937604"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/937604\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/937605"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=937604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=937604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=937604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}